Breaking News, Promotions & Moves

AMRI Names Chairman

Teva veteran Marth to serve in role held by D'Ambra

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

William S. Marth has been named chairman of the board at AMRI, a position that had been held by Thomas E. D’Ambra, Ph.D. since the company’s founding. AMRI’s board voted to separate the role of chairman and chief executive officer, and Dr. D’Ambra will retain his roles as a member of the board, president and chief executive officer. Mr. Marth joined the board in 2012.   Mr. Marth brings global experience in strategic planning, IR, R&D, supply chain and regulatory. He was fo...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters